InCarda Therapeutics Obtains $5,000,000 Series A Financing Round

  • Feed Type
  • Date
  • Company Name
    InCarda Therapeutics
  • Mailing Address
    150 Post Street San Francisco, CA 94108 USA
  • Company Description
    Here at InCarda, we see a better way. We see a future that includes improved quality of care for patients with acute cardiac conditions. We are committed to developing transformative therapies that patients can use themselves in the first moments of acute cardiovascular symptoms.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to further the company’s lead cardiovascular program for an inhaled therapy intended to treat paroxysmal atrial fibrillation (PAF).
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy